ASEP ASEP Medical Holdings Inc
- 0.135
- 0.0000.00%
ASEP Medical Holdings Inc News
Press Release: Asep Medical Holdings Inc. to Hold Significant Investor Information Webinar This Friday, March 22, 2024, at 4 Pm EST
Asep Medical Holdings Inc. to Hold Significant Investor Information Webinar this Friday, March 22, 2024, at 4 pm EST Canada NewsWire VANCOUVER, BC, March 18, 2024 CLICK HERE TO REGISTER VANCOUVER,
Update: ASEP Medical Holdings Reports Settlement of Debt; Down 6.8%
ASEP Medical Holdings Inc. (ASEP.CSE) overnight Thursday reported the issuance of shares for debt settlement. The company has issued about 3.9 million units at a deemed price of $0.20 per unit in a se
ASEP Medical Holdings Reports Settlement of Debt
ASEP Medical Holdings Inc. (ASEP.CSE) overnight Thursday reported the issuance of shares for debt settlement. The company has issued about 3.9 million units at a deemed price of $0.20 per unit in a se
ASEP Medical Holdings Granted Patent Approval for Its AI-based Sepsis Diagnostic Technology in the US
ASEP Medical Holdings Inc. (ASEP.CSE), which gained 20% on Friday over the weekend announced that its AI-based sepsis diagnostic technology, called SepsetER, has received patent approval in the United
Asep Medical Holdings Inc. Is Granted Patent Approval for Its AI-based Sepsis Diagnostic Technology in the US
VANCOUVER, BC, Nov. 24, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that the Company's AI-based sepsis d
Asep Inc. Obtains Exclusive Worldwide License From the University of British Columbia for Ground-breaking Medical Device Coating Technology
VANCOUVER, BC, July 31, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, as of July 21, 2023, it has completed the final milestone in its acquisition of SafeCoat Medical Inc. ("SafeCoat") and entered into an exclusive worldwide license agreement (the "Agreement") with the University of British Columbia ("UBC"), through its subsidiary SafeCoat, for the use, development and commercialization of a ground-breaking medical device coating technology (the "Technology").
ASEP MEDICAL HOLDINGS INC. ANNOUNCES ADOPTION OF LONG-TERM PERFORMANCE INCENTIVE PLAN, GRANT OF STOCK OPTIONS
Asep Medical Holdings Inc. to Hold Important Investor Information Webinar on January 24, 2023
CLARIFICATION - Asep Medical Holdings Inc. Provides Update on Its Prior Disclosure Regarding Proprietary Diagnostic & Therapeutic Technologies
VANCOUVER, BC, Dec. 28, 2022 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE:ASEP) (OTCQB:SEPSF) (FSE: JJ8) at the request of IIROC the Company would like to provide
Asep Medical Holdings Inc. Achieves Significant Milestones Addressing Antibiotic Failure Through Proprietary Diagnostic & Therapeutic Technologies
VANCOUVER, BC, Dec. 23, 2022 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE:ASEP) (OTCQB:SEPSF) (FSE: JJ8) is pleased to announce that, through its subsidiaries Sepset
Asep Medical Holdings Inc. Announces Grant of Stock Options
VANCOUVER, BC, Nov. 24, 2022 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE:ASEP) (OTCQB:SEPSF) (FSE: JJ8) is pleased to announce that, for recruitment, incentivization and
CSE Bulletin: Reinstatement - ASEP Medical Holdings Inc. (ASEP)
Toronto, Ontario--(Newsfile Corp. - Le 7 juin/June 2022) - Effective immediately, ASEP Medical Holdings Inc. will be reinstated for trading. The Company has rectified the default situation that gave r
CSE Bulletin: Suspensions (ASEP, EMER, GPO, LYNX, REO, YOUR, TSF)
Toronto, Ontario--(Newsfile Corp. - Le 10 mai/May 2022 ) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts
